Option chain shows key data for Roche Holding's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Roche Holding.

Roche Holding (OTC:RHHVF) Stock, Option Chain

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

News

Penny Stocks

Health Care

Movers

Trading Ideas

General

LMDX

RHHBF

RHHBY

RHHVF

Friday, LumiraDx Limited (NASDAQ: LMDX) appointed joint administrators for two subsidiaries.

Roche Agrees To Purchase Part Of COVID-19 Test Player LumiraDx Diagnostics Platform For $295M

Biotech

Small Cap

PSTX

Poseida Therapeutics Inc (NASDAQ: PSTX) released early efficacy and safety results from its Phase 1 study of P-BCMA-ALLO1, its BCMA-targeted allogeneic, T stem cell memory (TSCM)-rich chimeric antigen receptor 

Poseida Therapeutics&#39; New Treatment For Multiple Myeloma Shows Early Success In Clinical Trial

Large Cap

Roche Holdings AG (OTC: RHHBY) announced results from the Phase 3 INAVO120 study of the investigational therapy, inavolisib, in combination with palbociclib (Ibrance) and fulvestrant as a potenti

Roche&#39;s Combination Therapy Shows Improved Progression Free Survival In Certain Breast Cancer With Mutation

Roche Holding AG

Roche Holding

Comments

Roche Holding

Roche Holding (RHHVF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga